No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance

Obesity Research

Volumn 9, Issue 10, 2001, Pages 631-636

  Ricart, Wifredo ^a   Fernández Real, José Manuel ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Insulin action; Insulin growth factor I; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; OBESITY; PHYSIOLOGY; TIME;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; OBESITY; TIME FACTORS;

EID: 0035489461     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2001.83     Document Type: Article

References (40)

1. Cohick WS, Clemmons DR. Insulin-like growth factors. Annu Rev Physiol. 1993;55:131-53.
2. Frosch ER, Schmid C, Schwander J, Zapf JA. Actions of insulin growth factors. Annu Rev Physiol. 1985;47:443-67.
3. Bornfelt KE, Arnquvist HJ, Enberg B, Mathews LS, Norstedt G. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol. 1989;122:651-6.
4. Clemmons DR, Underwood LE. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr. 1991;11: 393-412.
5. Goya L, Rivero F, Martin MA, Arahuetes R, Hernández ER, Pascual-Leone AM. Effects of refeeding of undernourished and insulin treatment of diabetic neonatal rats on IGF and IGFBP. Am J Physiol. 1996;271:E223-E31.
6. Nyomba BL, Berard L, Murphy LJ. Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab. 1997;82:2177-81.
7. Conover CA, Lee PKD, Kanaley KA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab. 1992;74:1355-60.
8. Moller DE, Flier JS. Insulin resistance -mechanisms, syndromes, and implications. N Engl J Med. 1991;325:938-48.
9. DeFronzo RA, Bomadonna RC, Ferranini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15: 318-68.
10. Giacca A, Fisher SJ, Shi ZQ, et al. Insulin-like growth factor-I and insulin have no differential effects on glucose production and utilization under conditions of hyperglycemia. Endocrinology. 1994;134:2251-8.
11. Lang CH, Fan J, Frost RA, et al. Regulation of the insulin-like growth factor system by insulin in bum patients. J Clin Endocrinol Metab. 1996;81:2474-80.
12. Fernández-Real JM, Broch M, Ricart W, et al. Plasma sTNFR2 levels and insulin resistance. Diabetes. 1998;47:1757-62.
13. Fernández-Real JM, Grasa M, Casamitjana R, et al. Plasma total and glycosylated corticosteroid binding globulin (CBG) levels are associated with insulin secretion. J Clin Endocrinol Metab. 1999;84:3192-6.
14. Fernández-Real JM, Granada ML, Ruzafa A, Casamitjana R, Ricart W. Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin. Clin Endocrinol. 2000;52:159-64.
15. Juul A, Holm K, Kastrup K, et al. Free insulin like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab. 1997;68:2497-502.
16. Frystyck J, Vestbo E, Skjaerbaek, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism. 1995;44:37-44.
17. Smith RH. The endocrinology of obesity. Med Clin North Am. 1996;25:921-42.
18. Rasmussen MH, Frystyck J, Andersen T, Breum L, Chritiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-I (IGF-I), IGF-binding protein-3, insulin, and growth hormone. Metabolism. 1994;43:315-9.
19. Jones JI, Clemmons DR. Insulin growth factors and their binding proteins: biological actions. Endocrinol Rev. 1995;16: 3-34.
20. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin growth factors. Endocrinol Rev. 1994; 15:80-101.
21. Hizuka N, Takano K, Asakawa K, et al. Measurement of free form insulin-like growth factor I in human plasma. Growth Regul. 1991;1:51-5.
22. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FFBS Lett. 1994;348:185-91.
23. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. Measurement of free insulin-like growth factor I using immunoradiometric assay. J Immunoassay. 1994;15:263-76.
24. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor I and insulin. J Clin Invest. 1994;93:1131-9.
25. Cusi K, DeFronzo R. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. J Clin Endocrinol Metab. 2000;85:3077-84.
26. Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab. 1998;83:1467-71.
27. Villafuerte BC, Goldstein S, Robertson DG, Pao C-I, Murphy LJ, Philipps LS. Nutrition and somatomedin. XXIX: molecular regulation of IGFBP-I in hepatocyte primary culture. Diabetes. 1992;41:835-42.
28. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-A and IGF-I in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79:872-8.
29. Graubert MD, Goldsetin S, Phillips LS. Nutrition and somatomedin. XXVII: total and free IGF-I and IGF binding proteins in rats with streptozocin induced diabetes. Diabetes. 1991;40:95-965.
30. Conover CA, Butler PC, Wang M, Rizza RA, Lee PDK. Lack of growth hormone effect on insulin associated suppression of insulin-like growth factor binding protein 1 in humans. Diabetes. 1990;39:1251-6.
31. Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH. Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab. 1998;83:1935-9.
32. Suikkari AM, Koivisto VA, Rutanen AM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding proteins. J Clin Endocrinol Metab. 1988;66:266-72.
33. 2 cells. J Clin Endocrinol Metab. 1990;70:1062-7.
34. Lewitt MS, Baxter RC. Regulation of growth hormoneindependent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver explants. J Clin Endocrinol Metab. 1989;69:246-52.
35. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab. 1994;79:872-8.
36. Bereket A, Wilson TA, Blethen SL, et al. Effect of short-term fasting on free/disociable insulin-like growth factor I concentrations in normal human serum. J Clin Endocrinol Metab. 1996;81:4379-84.
37. Sharf JG, Ramadori G, Braulke T, Hartmann H. The cellular localization and hormonal regulation of bisynthesis of insulin-like growth factor binding proteins and of acid-labile subunit within rat liver. Prog Growth Factor Res. 1995;6:175-80.
38. Giudice LC. IGF-binding protein-3 protease regulation: how sweet it is! J Clin Endocrinol Metab. 1995;80:2279-81.
39. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-41.
40. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998;351:1393-6.